U.S., May 22 -- ClinicalTrials.gov registry received information related to the study (NCT06982651) titled 'A Study on the Safety, Pharmacokinetics, and Food Effects of MI078 Capsules' on April 24.
Brief Summary: This study was divided into three studies, namely, a single administration study, a food impact study, and a multiple administration study.
Study Start Date: Sept. 09, 2023
Study Type: INTERVENTIONAL
Condition:
Postpartum Depression
Intervention:
DRUG: MI078
Dosage Form: Capsule Specification: 25 mg Administration and Dosage: Oral. 1 capsule per dose, once daily. Duration of Treatment: 1 day
Dosage Form: Capsule Specification: 50 mg Administration and Dosage: Oral. 1 capsule per dose, once daily. Duration of Treatment: 1 d...